关注
Toshiyuki OHTAKE
Toshiyuki OHTAKE
Shiseido Co. Ltd.
在 shiseido.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Metabolomics-driven approach to solving a CoA imbalance for improved 1-butanol production in Escherichia coli
T Ohtake, S Pontrelli, WA Laviña, JC Liao, SP Putri, E Fukusaki
Metabolic engineering 41, 135-143, 2017
992017
Applicability of an Integrated Testing Strategy consisting of in silico, in chemico and in vitro assays for evaluating the skin sensitization potencies of isocyanates
T Ohtake, Y Maeda, T Hayashi, H Yamanaka, M Nakai, M Takeyoshi
Toxicology 393, 9-14, 2018
202018
Metabolomics-driven identification of the rate-limiting steps in 1-propanol production
T Ohtake, N Kawase, S Pontrelli, K Nitta, WA Laviña, CR Shen, SP Putri, ...
Frontiers in Microbiology 13, 2022
42022
In chemico sequential testing strategy for assessing the photoallegic potential
H Nishida, T Ohtake, T Ashikaga, M Hirota, S Onoue, Y Seto, Y Tokura, ...
Toxicology in Vitro 77, 105245, 2021
42021
Reactive oxygen species (ROS) assay-based photosafety screening for complex ingredients: Modification of the ROS assay protocol
H Ohtake, Y Tokuyoshi, Y Iyama, T Nukaga, H Nishida, T Ohtake, M Hirota, ...
The Journal of Toxicological Sciences 47 (11), 483-492, 2022
12022
Causes and countermeasure for blank absorbance increase in the ROS assay
T Ohtake, M Hirota
The Journal of Toxicological Sciences 47 (3), 109-116, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–6